ReviewJournal of clinical medicine2020

Advances in the Management of Medullary Thyroid Carcinoma: Focus on Peptide Receptor Radionuclide Therapy.

Erika Grossrubatscher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.